These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24215237)

  • 1. Discovery and characterization of a novel dihydroisoxazole class of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiators.
    Patel NC; Schwarz J; Hou XJ; Hoover DJ; Xie L; Fliri AJ; Gallaschun RJ; Lazzaro JT; Bryce DK; Hoffmann WE; Hanks AN; McGinnis D; Marr ES; Gazard JL; Hajós M; Scialis RJ; Hurst RS; Shaffer CL; Pandit J; O'Donnell CJ
    J Med Chem; 2013 Nov; 56(22):9180-91. PubMed ID: 24215237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive allosteric modulation of AMPA receptors from efficacy to toxicity: the interspecies exposure-response continuum of the novel potentiator PF-4778574.
    Shaffer CL; Hurst RS; Scialis RJ; Osgood SM; Bryce DK; Hoffmann WE; Lazzaro JT; Hanks AN; Lotarski S; Weber ML; Liu J; Menniti FS; Schmidt CJ; Hajós M
    J Pharmacol Exp Ther; 2013 Oct; 347(1):212-24. PubMed ID: 23899905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
    Ryder JW; Falcone JF; Manro JR; Svensson KA; Merchant KM
    J Pharmacol Exp Ther; 2006 Oct; 319(1):293-8. PubMed ID: 16803862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discovery and characterization of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiator N-{(3S,4S)-4-[4-(5-cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242).
    Shaffer CL; Patel NC; Schwarz J; Scialis RJ; Wei Y; Hou XJ; Xie L; Karki K; Bryce DK; Osgood SM; Hoffmann WE; Lazzaro JT; Chang C; McGinnis DF; Lotarski SM; Liu J; Obach RS; Weber ML; Chen L; Zasadny KR; Seymour PA; Schmidt CJ; Hajós M; Hurst RS; Pandit J; O'Donnell CJ
    J Med Chem; 2015 May; 58(10):4291-308. PubMed ID: 25905800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationships.
    Bang-Andersen B; Lenz SM; Skjaerbaek N; Søby KK; Hansen HO; Ebert B; Bøgesø KP; Krogsgaard-Larsen P
    J Med Chem; 1997 Aug; 40(18):2831-42. PubMed ID: 9288165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.
    Murray TK; Whalley K; Robinson CS; Ward MA; Hicks CA; Lodge D; Vandergriff JL; Baumbarger P; Siuda E; Gates M; Ogden AM; Skolnick P; Zimmerman DM; Nisenbaum ES; Bleakman D; O'Neill MJ
    J Pharmacol Exp Ther; 2003 Aug; 306(2):752-62. PubMed ID: 12730350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel series of positive modulators of the AMPA receptor: discovery and structure based hit-to-lead studies.
    Jamieson C; Basten S; Campbell RA; Cumming IA; Gillen KJ; Gillespie J; Kazemier B; Kiczun M; Lamont Y; Lyons AJ; Maclean JK; Moir EM; Morrow JA; Papakosta M; Rankovic Z; Smith L
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5753-6. PubMed ID: 20805031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity.
    Sakurai F; Yukawa T; Kina A; Murakami M; Takami K; Morimoto S; Seto M; Kamata M; Yamashita T; Nakashima K; Narita N; Bettini E; Ugolini A; Corsi M; Hasui T
    Bioorg Med Chem; 2022 Feb; 56():116576. PubMed ID: 35051811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
    Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES
    J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of lead optimization with crystallography for a membrane-bound ion channel target: discovery of a new class of AMPA receptor positive allosteric modulators.
    Ward SE; Harries M; Aldegheri L; Austin NE; Ballantine S; Ballini E; Bradley DM; Bax BD; Clarke BP; Harris AJ; Harrison SA; Melarange RA; Mookherjee C; Mosley J; Dal Negro G; Oliosi B; Smith KJ; Thewlis KM; Woollard PM; Yusaf SP
    J Med Chem; 2011 Jan; 54(1):78-94. PubMed ID: 21128618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and pharmacology of novel 7-substituted 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides as positive allosteric modulators of AMPA receptors.
    Francotte P; Tullio Pd; Goffin E; Dintilhac G; Graindorge E; Fraikin P; Lestage P; Danober L; Thomas JY; Caignard DH; Pirotte B
    J Med Chem; 2007 Jun; 50(13):3153-7. PubMed ID: 17552506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tweaking Subtype Selectivity and Agonist Efficacy at (S)-2-Amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propionic acid (AMPA) Receptors in a Small Series of BnTetAMPA Analogues.
    Wang SY; Larsen Y; Navarrete CV; Jensen AA; Nielsen B; Al-Musaed A; Frydenvang K; Kastrup JS; Pickering DS; Clausen RP
    J Med Chem; 2016 Mar; 59(5):2244-54. PubMed ID: 26862980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension tests.
    Andreasen JT; Gynther M; Rygaard A; Bøgelund T; Nielsen SD; Clausen RP; Mogensen J; Pickering DS
    Neurosci Lett; 2013 Jun; 546():6-10. PubMed ID: 23643996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A stereochemical anomaly: the cyclised (R)-AMPA analogue (R)-3-hydroxy-4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridine-5-carboxylic acid [(R)-5-HPCA] resembles (S)-AMPA at glutamate receptors.
    Vogensen SB; Greenwood JR; Varming AR; Brehm L; Pickering DS; Nielsen B; Liljefors T; Clausen RP; Johansen TN; Krogsgaard-Larsen P
    Org Biomol Chem; 2004 Jan; 2(2):206-13. PubMed ID: 14737644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of Tet-AMPA [tetrazolyl-2-amino-3-(3-hydroxy-5-methyl- 4-isoxazolyl)propionic acid] analogues at ionotropic glutamate receptors GluR1-GluR4. The molecular basis for the functional selectivity profile of 2-Bn-Tet-AMPA.
    Jensen AA; Christesen T; Bølcho U; Greenwood JR; Postorino G; Vogensen SB; Johansen TN; Egebjerg J; Bräuner-Osborne H; Clausen RP
    J Med Chem; 2007 Aug; 50(17):4177-85. PubMed ID: 17672447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excitatory amino acid receptor antagonists: resolution, absolute stereochemistry, and pharmacology of (S)- and (R)-2-amino-2-(5-tert-butyl-3-hydroxyisoxazol-4-yl)acetic acid (ATAA).
    Johansen TN; Frydenvang K; Ebert B; Madsen U; Krogsgaard-Larsen P
    Chirality; 1997; 9(5-6):529-36. PubMed ID: 9329180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel series of positive modulators of the AMPA receptor: structure-based lead optimization.
    Jamieson C; Campbell RA; Cumming IA; Gillen KJ; Gillespie J; Kazemier B; Kiczun M; Lamont Y; Lyons AJ; Maclean JK; Martin F; Moir EM; Morrow JA; Pantling J; Rankovic Z; Smith L
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6072-5. PubMed ID: 20817521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures.
    Lockhart BP; Rodriguez M; Mourlevat S; Peron P; Catesson S; Villain N; Galizzi JP; Boutin JA; Lestage P
    Eur J Pharmacol; 2007 Apr; 561(1-3):23-31. PubMed ID: 17331496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMPA receptor agonists: resolution, configurational assignment, and pharmacology of (+)-(S)- and (-)-(R)-2-amino-3-[3-hydroxy-5-(2-pyridyl)-isoxazol-4-yl]-propionic acid (2-Py-AMPA).
    Johansen TN; Ebert B; Falch E; Krogsgaard-Larsen P
    Chirality; 1997; 9(3):274-80. PubMed ID: 9176992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AMPA receptor as a therapeutic target: current perspectives and emerging possibilities.
    Mellor IR
    Future Med Chem; 2010 May; 2(5):877-91. PubMed ID: 21426207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.